CDMOs Cautiously Address Expansion
These are high times for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). A record flood of external financing is flowing into the bio/pharmaceutical industry. Global bio/pharmaceutical companies are …
Proprietary Global Sourcing Intelligence in an Instant
Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more
CFDA Approvals See First Increase Since 2011
Reversing the trend seen over the last few years, approvals for new drug products and clinical trials in China rose in 2014.
The increase could represent less a true increase and more a normalization of review and approval rates, suggested Carl Williams, a former US FDA investigator with experience in China. The CFDA’s increased attention to GMP compliance likely was…